Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes – CV risk reductionukmlamrcgp aktpanemrcp part 1prescribing safety assessment

A 48-year-old with long-standing type 2 diabetes and obesity asks about cardioprotective glucose-lowering therapy after metformin. eGFR 58. Which class provides cardiovascular benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.